Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (187) Arrow Down
Filter Results: (187) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (309)
    • People  (1)
    • News  (83)
    • Research  (187)
    • Multimedia  (4)
  • Faculty Publications  (124)

Show Results For

  • All HBS Web  (309)
    • People  (1)
    • News  (83)
    • Research  (187)
    • Multimedia  (4)
  • Faculty Publications  (124)
← Page 6 of 187 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • 2003
  • Case

Corning Microarray Technologies

By: Vijay Govindarajan, Chris Trimble and Gautam Bellur
In mid-2000, the scientific community reached a momentous milestone—the complete mapping of the human genome. Researchers in the field of genomics were anxious to dig into a tremendous array of newly possible scientific inquiries, and needed efficient experimental... View Details
Keywords: Expansion; Genetics; Manufacturing Industry; Industrial Products Industry
Citation
Related
Govindarajan, Vijay, Chris Trimble, and Gautam Bellur. "Corning Microarray Technologies." 2003. (Case No. 2-0020.)
  • December 2000
  • Case

Paradigm Genetics: The Industrialization of Genomics

By: Ray A. Goldberg, Carin-Isabel Knoop and Laure Mougeot Stroock
Keywords: Genetics; Biotechnology Industry
Citation
Find at Harvard
Related
Goldberg, Ray A., Carin-Isabel Knoop, and Laure Mougeot Stroock. "Paradigm Genetics: The Industrialization of Genomics." Harvard Business School Case 901-011, December 2000.
  • December 2012
  • Teaching Note

Gene Patents (A) (TN)

By: Richard G. Hamermesh and Matthew Preble
This is the teaching note for case Gene Patents (A). In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our... View Details
Keywords: Biotech; Human Genome; Patents; Genetics; Biotechnology Industry; United States
Citation
Purchase
Related
Hamermesh, Richard G., and Matthew Preble. "Gene Patents (A) (TN)." Harvard Business School Teaching Note 813-099, December 2012.
  • October – December 1998
  • Article

The Evidence Does Not Speak for Itself: Expert Witnesses and the Organization of DNA Typing Companies

By: Arthur A. Daemmrich
Keywords: Genetics; Business Ventures
Citation
Find at Harvard
Related
Daemmrich, Arthur A. "The Evidence Does Not Speak for Itself: Expert Witnesses and the Organization of DNA Typing Companies." Special Issue on Contested Identities: Science, Law and Forensic Practice. Social Studies of Science 28, nos. 5/6 (October–December 1998): 741–772.
  • February 2008 (Revised August 2008)
  • Case

EXACT Sciences Corp.: Commercializing a Diagnostic Test

By: Regina E. Herzlinger
This case addresses the challenges of commercializing molecular diagnostics. Along the way, it explains the technology, payment system, and the measures used to assess the value of a diagnostic test. View Details
Keywords: Health Testing and Trials; Genetics; Science-Based Business; Commercialization; Biotechnology Industry
Citation
Find at Harvard
Related
Herzlinger, Regina E. "EXACT Sciences Corp.: Commercializing a Diagnostic Test." Harvard Business School Case 308-090, February 2008. (Revised August 2008.)
  • 15 Jan 2018
  • Research & Ideas

A Better Business Model for Fighting Cancer

question—it’s clear.” Simply put, inefficiencies in the development of precision medicine can best be addressed by a business-analysis approach. With the mapping of the human genome completed 15 years ago, the sci-fi concept of using a cancer patient’s View Details
Keywords: by Julia Hanna; Health; Pharmaceutical
  • June 2011 (Revised October 2013)
  • Case

Gene Patents (A)

By: Richard Hamermesh, David Kiron and Phillip Andrews
In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our increasing knowledge of the Human Genome. The case issues... View Details
Keywords: Courts and Trials; Patents; Genetics; Judgments; Science-Based Business; Biotechnology Industry; United States
Citation
Educators
Purchase
Related
Hamermesh, Richard, David Kiron, and Phillip Andrews. "Gene Patents (A)." Harvard Business School Case 811-089, June 2011. (Revised October 2013.)
  • 1997
  • Chapter

Patent Scope and Emerging Industries: Biotechnology, Software, and Beyond

By: Josh Lerner and Robert P. Merges
Keywords: Patents; Applications and Software; Genetics; Information Technology Industry; Biotechnology Industry
Citation
Find at Harvard
Related
Lerner, Josh, and Robert P. Merges. "Patent Scope and Emerging Industries: Biotechnology, Software, and Beyond." In Competing in the Age of Digital Convergence, edited by D. B. Yoffie, 301–324. Boston: Harvard Business School Press, 1997.
  • 29 May 2001
  • Research & Ideas

Genomics: Can We Start Making Money Now?

drugs, and will they be less expensive?' My answer is, 'I don't know, and probably not.' Lechleiter was one of several panelists to discuss, "Breaking the Genetic Code: The Business of Life Science in the 21st Century" at the... View Details
Keywords: by Sean Silverthorne
  • 07 Aug 2000
  • Research & Ideas

The Business of Biotech

cells in cancer patients) generated more than $2 billion in sales last year. Millennium Pharmaceuticals: Alan Crane (photo: Shelly R. Harrison) As the ability to analyze a patient's genetic material is developed, however, many believe... View Details
Keywords: by Julia Hanna; Biotechnology; Health; Technology
  • June 2005 (Revised July 2006)
  • Background Note

Note on the Convergence Between Genomics & Information Technology

By: David B. Yoffie, Dharmesh M Mehta and Rachel Sha
Focuses on the convergence between the genomics and semiconductor industries, in particular organ printing, DNA computing, biomolecular sensory networks, and DNA microarrays. Explains what this newly converged world looks like based on current research and findings in... View Details
Keywords: Genetics; Information Technology; Business Model; Disruptive Innovation; Biotechnology Industry; Information Technology Industry; Semiconductor Industry; Medical Devices and Supplies Industry
Citation
Find at Harvard
Related
Yoffie, David B., Dharmesh M Mehta, and Rachel Sha. "Note on the Convergence Between Genomics & Information Technology." Harvard Business School Background Note 705-500, June 2005. (Revised July 2006.)
  • 23 Nov 2010
  • First Look

First Look: November 23

case:http://cb.hbsp.harvard.edu/cb/product/811014-PDF-ENG Generation Health: A Pioneer in Genetics Benefit Management (A) Robert F. Higgins, Jeffrey D. Marrazzo, and Rachel GordonHarvard Business School Case 810-007 Generation Health, a... View Details
Keywords: Sean Silverthorne
  • 02 Jul 2001
  • Research & Ideas

Ray A. Goldberg

issues," he beams, "from land reform in Mexico to the development of the genetically modified tomato." "The genetic research revolution is changing our global economy and society more... View Details
Keywords: by Staff; Agriculture & Agribusiness
  • 26 Jun 2000
  • Research & Ideas

Presentation Round-Up

get out of the way. But we also have to be prepared. Where the market fails to provide the service, we have to step in." Genes On The Web In a discussion moderated by HBS Professor Josh Lerner, participants in the panel on "Genes on the Web" emphasized the positive... View Details
Keywords: by Martha Lagace & Kenneth Liss; Technology; Communications; Telecommunications
  • June 1997 (Revised September 1997)
  • Case

Genset Initial Public Offering (B)

By: Paul A. Gompers and Jeffrey M. Anapolsky
Supplements the (A) case. View Details
Keywords: Business Model; Initial Public Offering; Genetics; Going Public; Management Teams; Biotechnology Industry; France; United States
Citation
Educators
Purchase
Related
Gompers, Paul A., and Jeffrey M. Anapolsky. "Genset Initial Public Offering (B)." Harvard Business School Case 297-097, June 1997. (Revised September 1997.)
  • June 1997 (Revised March 2001)
  • Case

Genset Initial Public Offering (A)

By: Paul A. Gompers and Jeffrey M. Anapolsky
Pascal Brandys, founder and CEO of Genset, must decide whether to take this young biotechnology company public. If so, should he do a dual offering in both France and the U.S.? The case also explores the business models in genomics research. View Details
Keywords: Business Model; Initial Public Offering; Genetics; Going Public; Management Teams; Biotechnology Industry; France; United States
Citation
Educators
Purchase
Related
Gompers, Paul A., and Jeffrey M. Anapolsky. "Genset Initial Public Offering (A)." Harvard Business School Case 297-096, June 1997. (Revised March 2001.)
  • 07 Apr 2003
  • Research & Ideas

Three Steps for Crisis Prevention

genetically modified foods in Europe. Betting the company on a "life sciences" vision, Shapiro had sold or spun off Monsanto's traditional chemical businesses and moved aggressively to acquire seed companies. Dazzled by the... View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
  • September 2000
  • Case

Novartis Agricultural Discovery Institute (A)

Steve Briggs, a PhD biologist, is asked to propose a strategy to take global life-science giant Novartis into the rapidly expanding field of plant genomics. View Details
Keywords: Design; Plant-Based Agribusiness; Genetics; Infrastructure; Biotechnology Industry; Agriculture and Agribusiness Industry
Citation
Educators
Purchase
Related
West, Jonathan, and Christian G. Kasper. "Novartis Agricultural Discovery Institute (A)." Harvard Business School Case 601-010, September 2000.
  • 17 Dec 2001
  • Research & Ideas

Enterprising Women

is developing stem cell products to treat cancer, genetic disorders, and immune deficiencies. Keep Business Model Fluid "Know your timing," advised Susan Willet Bird, founder and president of Women.future, an organization that... View Details
Keywords: by Julia Hanna
  • 25 Jul 2011
  • Research & Ideas

How Disruptive Innovation is Remaking the University

against the same criteria applied to his or her predecessor. The way things are done is determined not by individual preference but by institutional procedure written into the genetic code. There is evolution in the university, though its... View Details
Keywords: by Clayton M. Christensen & Henry J. Eyring; Education
  • ←
  • 6
  • 7
  • 8
  • 9
  • 10
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.